一个国际比较分析和可持续生物类似药市场的路线图
Khalid A Alnaqbi1, Agnès Bellanger2, Alex Brill3
1Tawam Hospital, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates.
Frontiers in pharmacology
|September 11, 2023
概括
这项研究评估了17个国家的生物相似政策. 可持续政策确保安全,质量和成本节约,同时促进竞争,以实现长期的市场可行性.
科学领域:
- 制药政策 制药政策
- 卫生经济学 卫生经济学
- 生物技术是生物技术.
背景情况:
- 在全球范围内,生物类似药的吸收率有所不同,这引发了对市场可持续性的担忧.
- 评估生物类似政策的长期可行性对于市场稳定至关重要.
研究的目的:
- 评估整个产品生命周期内生物类似药政策的可持续性.
- 为提高生物类似药市场可持续性提出建议.
主要方法:
- 在不同地区的17个国家对生物类似政策的比较分析.
- 通过文献审查,专家验证和咨询委员会进行政策可持续性评估.
主要成果:
- 欧洲国家,有更多的经验和发达的框架,通常表现出更高的可持续性得分.
- 可持续的要素包括研发支持,质量保证,HTA豁免和误解管理.
- 生物类似的合同,教育和理解需要在全球范围内进行改进.
- 政策的可持续性取决于环境,受到医疗保健系统和市场准入的影响.
结论:
- 可持续的生物类似药政策必须首先确保安全,质量,供应和成本节约.
- 随着经验的增长,政策应该优化采用和解决误解.
- 长期可持续性需要促进竞争,扩大治疗选择,并创造一个稳定的市场环境.
相关概念视频
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Global Regulatory Systems
44
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
44
Pharmacokinetic Models: Comparison and Selection Criterion
103
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
103
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K


